BOC Sciences - Products
London
BOC Sciences provides various research (bio)chemicals: inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities, metabolites, APIs, natural compounds, ADCs, and chiral compounds.
| Product | Description | |
|---|---|---|
| Darifenacin Impurities | Darifenacin Impurities are critical for quality control in the pharmaceutical industry, particularly in developing and ensuring the purity of darifenacin-based treatments for overactive bladder. These impurities help assess the safety and efficacy of medications by identifying and characterizing potential degradation products and synthesis byproducts of darifenacin. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. |  London |
| Darunavir | Darunavir is a second generation protease inhibitor that targets the HIV-1 protease. It demonstrates extremely potent activity against the infectivity and replication of various strains of HIV-1, including several that are resistant to first generation protease inhibitors (IC50s = 3-30 nM). Darunavir has been reported to inhibit both cell-free diffusion and cell-to-cell spread of HIV-1 with IC50 values of 2.5 and 2.8 nM, respectively. Uses: Hiv protease inhibitors. Group: Pharmaceutical. CAS No. 206361-99-1. Pack Sizes: 50 mg. Product ID: B0084-062615. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Darunavir Ethanolate | Darunavir Ethanolate is a nonpeptidic HIV protease inhibitor, used to treat HIV infection. Uses: Hiv protease inhibitors. Group: Pharmaceutical. CAS No. 635728-49-3. Pack Sizes: 1 g. Product ID: B0084-459375. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Darunavir Impurities | Darunavir Impurities are pivotal in pharmaceutical development, specifically utilized for assessing the purity, safety, and efficacy of darunavir, an antiretroviral drug used to treat HIV-1 infections. These impurities aid in refining darunavir formulations, ensuring optimal therapeutic outcomes and adherence to stringent regulatory standards. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Darusentan | Darusentan is a selective endothelin-1 receptor A inhibitor. Darusentan is identified as the treatment of congestive heart failure, hypertension and cancers. It blocks endothelin ETA receptor thus results in an increase of sodium and potassium excretion in aging rats. Uses: Endothelin receptor antagonists. Group: Pharmaceutical. CAS No. 171714-84-4. Pack Sizes: 100 mg. Product ID: B0084-085682. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Darutoside | Darutoside is isolated from the herb of Siegesbeckia orientalis. It can improve skin elasticity, surface appearance and stretch mark removal, through soothing the skin, decreasing inflammation, restoring collagen and promoting collagen production. Group: Pharmaceutical. CAS No. 59219-65-7. Pack Sizes: 10 mg. Product ID: NP1520. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| dasabuvir | Dasabuvir is an antiviral drug for the treatment of hepatitis C. It inhibits hepatitis C virus (HCV) non-nucleoside NS5B palm polymerase to suppress RNA replicase. Dasabuvir is commonly used in combination with ombitasvir/paritaprevir/ritonavir to effect on HCV type 1. Uses: The treatment of hepatitis c. Group: Pharmaceutical. CAS No. 1132935-63-7. Pack Sizes: 100 mg. Product ID: B0084-462255. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Dasatinib | Dasatinib, also known as BMS-354825, is an orally bioavailable synthetic small molecule-inhibitor of SRC-family protein-tyrosine kinases. Dasatinib binds to and inhibits the growth-promoting activities of these kinases. Apparently because of its less stringent binding affinity for the BCR-ABL kinase, dasatinib has been shown to overcome the resistance to imatinib of chronic myeloid leukemia (CML) cells harboring BCR-ABL kinase domain point mutations. SRC-family protein-tyrosine kinases interact with variety of cell-surface receptors and participate in intracellular signal transduction pathways; tumorigenic forms can occur through altered regulation or expression of the endogenous protein and by way of virally-encoded kinase genes. Group: Pharmaceutical. CAS No. 302962-49-8. Pack Sizes: 25 g. Product ID: NP3264. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Dasatinib Impurities | Dasatinib Impurities are critical for evaluating the purity and efficacy of dasatinib, a tyrosine kinase inhibitor utilized in treating chronic myeloid leukemia and acute lymphoblastic leukemia. Analyzing these impurities ensures the safety and effectiveness of dasatinib in clinical applications, supporting its continued use in cancer therapy. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Dasatinib N-Oxide | Dasatinib N-Oxide is an oxidative metabolite of Dasatinib (M5 metabolite). Group: Pharmaceutical. CAS No. 910297-52-8. Pack Sizes: 5 mg. Product ID: B0708-469805. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Dasotraline hydrochloride | Dasotraline hydrochloride, also called as SEP-225289 hydrochloride, is a metabolite of Sertraline and a novel inhibitor of dopamine and norepinephrine reuptake that blocks dopamine, norepinephrine, andserotonin transporters (IC50 = 4, 6, and 11 nM, respectively). Group: Pharmaceutical. CAS No. 675126-08-6. Pack Sizes: 5 mg. Product ID: B0084-241506. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| D-Asp(9)-Semaglutide | D-Asp(9)-Semaglutide is an impurity of Semaglutide, which is a glucagon-like peptide-1 (GLP-1) receptor agonist used to treat type 2 diabetes. Group: Pharmaceutical. Pack Sizes: 5 mg. Product ID: B1370-449824. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Daturabietatriene | Daturabietatriene is isolated from the heartwoods of Pinus yunnanensis. Group: Pharmaceutical. CAS No. 65894-41-9. Pack Sizes: 5 mg. Product ID: NP1392. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Daunorubicin EP Impurity B | Daunorubicinol, a metabolite of Daunorubicin, is an anthracycline antineoplastic antibiotic with therapeutic effects similar to those of doxorubicin. Group: Pharmaceutical. CAS No. 28008-55-1. Pack Sizes: 25 mg. Product ID: B0709-469824. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Daunorubicin hydrochloride | Daunorubicin HCl inhibits both DNA and RNA synthesis and inhibits DNA synthesis with Ki of 0.02 μM. Uses: Adcs cytotoxin. Group: Pharmaceutical. CAS No. 23541-50-6. Pack Sizes: 1 g. Product ID: BBF-03858. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Daunorubicin Impurities | Daunorubicin Impurities, critical reference standards in the biomedical sector, play a pivotal role in the quality control of daunorubicin formulations. These impurities aid in the identification and quantification processes during the production of daunorubicin, a chemotherapy drug used in the treatment of leukemia, ensuring the therapeutic efficacy and safety of the final product. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Daunorubicinol hydrochloride | Daunorubicinol Hydrochloride is a metabolite of Daunorubicin, which is an anthracycline antibiotic used in the treatment of acute myeloid and lymphocytic leukemia, with adverse reactions such as cardiotoxicity and bone marrow suppression. Group: Pharmaceutical. CAS No. 28008-53-9. Pack Sizes: 2.5 mg. Product ID: B0709-004063. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Daurichromenic acid | Daurichromenic acid, isolated from the herbs of Rhododendron dauricum, is a terpenophenol with potent anti-HIV activity. Uses: Anti-hiv activity. Group: Pharmaceutical. CAS No. 82003-90-5. Pack Sizes: 1 mg. Product ID: NP4792. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| DAURICINE | Dauricine had a good inhibition effect on tumor cells in urinary system. At the same time, Dauricine has certain inhibition effects on the primary cultured tumor cell. Uses: Antiarrhythmic. Group: Pharmaceutical. CAS No. 524-17-4. Pack Sizes: 10 mg. Product ID: NP0049. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| DB-2073 | DB-2073 is produced by the strain of Pseudomonas B-9004. It has the activity against streptococcus pneumoniae and tinea gypsum mold. Group: Pharmaceutical. CAS No. 39341-78-1. Pack Sizes: 100 mg. Product ID: BBF-02800. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| DBCO-NHS ester | DBCO-NHS ester. Group: Pharmaceutical. CAS No. 1353016-71-3. Pack Sizes: 1 g. Product ID: BADC-00933. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| DBCO-PEG4-NHS ester | DBCO-PEG4-NHS ester is PEG derivative used as a cross-linker to react with primary amines. Group: Pharmaceutical. CAS No. 1427004-19-0. Pack Sizes: 100 mg. Product ID: B2699-064933. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| DBCO-PEG4-vc-PAB-MMAF | DBCO-PEG4-vc-PAB-MMAF is a drug-linker conjugate for ADC by using Monomethylauristatin F (MMAF, a potent tubulin polymerization inhibitor), linked via DBCO-PEG4-vc-PAB. Group: Pharmaceutical. Pack Sizes: 5 mg. Product ID: BADC-00756. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| DBeQ | DBeQ inhibits p97 competitively with respect to ATP, with Ki of 3.2 μM, suggesting that it binds to the active site of the D2 domain. Group: Pharmaceutical. CAS No. 177355-84-9. Pack Sizes: 50 mg. Product ID: B0084-463451. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| dBET1 | dBET1 is a potent BRD4 protein degrader composed of a BET bromodomain inhibitor (+)-JQ1 and a sedative drug thalidomide. The (+)-JQ1 portion binds to the BET bromodomains, and the thalidomide binds to cereblon to form a cereblon E3 ubiquitin ligase complex, inducing cereblon-dependent BET protein degradation. Group: Pharmaceutical. CAS No. 1799711-21-9. Pack Sizes: 50 mg. Product ID: B1370-285214. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| D-β-Homoalanine hydrochloride | D-β-Homoalanine hydrochloride, an amino acid derivative, is of significant interest owing to its multiple applications ranging from peptide synthesis to the development of natural product antibiotics. Research has also been conducted to unveil its potential antiviral and antitumor properties, representing an area of pharmacological significance with far-reaching implications. Group: Pharmaceutical. CAS No. 58610-42-7. Pack Sizes: 100 g. Product ID: BAT-006867. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Dbta Impurities | Dbta Impurities, integral to pharmaceutical research, are critical in ensuring the purity and effectiveness of active pharmaceutical constituents. Their presence is vital in drug innovation, particularly in scrutinizing safety profiles pertinent to bacterial infection therapies and neurodegenerative conditions, thereby facilitating quality assurance and adherence to regulatory standards. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| DC-1 | DC-1 is a cytotoxic agent, used as the cytotoxic component in antibody-drug conjugates. Group: Pharmaceutical. Pack Sizes: 5 mg. Product ID: BADC-00335. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| DCC-2618 | DCC-2618 inhibits normal and mutant KIT kinase at the nanomol level. The targets are wt c-KIT, c-KIT mutants, PDGFR alpha, PDGFR beta, KDR and cFMS. DCC-2618 inhibits mutant KIT in GIST patient cell line (GIST T1 pKIT western Ex11 deletion) at a IC 50 of 2 nM. Deciphera's technology has identified DCC-2618 as a molecule which can be developed as second line therapy for imatinib and sunitinib resistant GIST patients with the potential to progress to frontline GIST therapy. DCC-2618 has been designed to effectively inhibit the imatinib and sunitinib-sensitive KIT juxtamembrane domain mutants (JMD) as well as secondary resistant KIT kinase-domain mutants. DCC-2618 additionally targets PDGFR alpha oncogenic mutants. Group: Pharmaceutical. CAS No. 1225278-16-9. Pack Sizes: 50 mg. Product ID: B0084-457687. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| DC-Cholesterol hydrochloride | DC-Cholesterol is a cholesterol analog that transfects DNA and RNA via cationic liposome formulation with phospholipids. Group: Pharmaceutical. CAS No. 166023-21-8. Pack Sizes: 250 mg. Product ID: B1370-071961. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| DCPIB | DCPIB is a potent and selective volume-sensitive anion channel (VSAC) blocker, swell in various cardiovascular tissues (IC50 = 4.1 μM in CPAE cells). It inhibits glucose-stimulated insulin in intact β-cells, and reverses cell swelling-induced action potential duration shortening in atrial myocytes and inhibits astroglial swelling in vitro. Group: Pharmaceutical. CAS No. 82749-70-0. Pack Sizes: 50 mg. Product ID: B2693-034500. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| D-Cys(2)-Octreotide trifluoroacetate salt | D-Cys(2)-Octreotide is an impurity of Octreotide, which is a synthetic long-acting cyclic octapeptide used as a more potent inhibitor of growth hormone, glucagon, and insulin than somatostatin. Group: Pharmaceutical. Pack Sizes: 10 mg. Product ID: B1370-449817. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| D-Desthiobiotin | D-Desthiobiotin is an analogue of Biotin and a protein cross-linking agent. It is used in the preparation of agarose matrices for affinity-based isolation of streptavidin-fluorophore conjugates. Group: Pharmaceutical. CAS No. 533-48-2. Pack Sizes: 1 g. Product ID: B2699-025811. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Deacetylasperulosidic acid | Deacetylasperulosidic acid is a natural compound found in Morinda citrifolia fruit with antioxidant activity. Deacetylasperulosidic acid inhibited the reduction of ear swelling, and also cancelled the suppression of IL-2 production along with the activation of natural killer cells in the same manner as that of Noni-ext. Group: Pharmaceutical. CAS No. 14259-55-3. Pack Sizes: 25 mg. Product ID: B1370-452428. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Deacetyl ganoderic acid F | Deacetyl ganoderic acid F, a natural triterpenoid compound obtained from the Ganoderma lucidum, displays an array spectrum of pharmacological activities, particularly antitumor, immunomodulatory, and antiviral properties, to name a few. Moreover, Deacetyl ganoderic acid F exhibits effective outcomes for treating liver-associated diseases, for instance, hepatic fibrosis, liver cancer, and hepatitis, thereby, promising a potential therapeutic agent for liver dysfunctions. Group: Pharmaceutical. CAS No. 100665-44-9. Pack Sizes: 5 mg. Product ID: B0005-465655. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Deacetylpseudolaric acid A | Deacetylpseudolaric acid A isolated from the root bark of Pseudolarix amabilis. Group: Pharmaceutical. CAS No. 82508-37-0. Pack Sizes: 1 mg. Product ID: NP1452. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Deacetylpseudolaric acid C2 | Deacetylpseudolaric acid C2 isolated from the root bark of Pseudolarix amabilis. Uses: Demethoxydeacetoxypseudolaric acid b. Group: Pharmaceutical. CAS No. 82508-36-9. Pack Sizes: 1 mg. Product ID: NP1334. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Deacetylxylopic acid | Deacetylxylopic acid is isolated from the herbs of Nouelia insignis. Group: Pharmaceutical. CAS No. 6619-95-0. Pack Sizes: 5 mg. Product ID: NP1394. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Deapi-platycodin D3 | Deapi-platycodin D3 is a triterpenoid compound found in the roots of Platycodon grandiflorum A. de Candolle (APG), of which the aqueous extract is used as a therapy of inflammatory pulmonary diseases. Group: Pharmaceutical. CAS No. 67884-05-3. Pack Sizes: 5 mg. Product ID: B0005-053717. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Decamethoxine | Decamethoxine, a cationic gemini surfactant, has strong bactericidal and fungicidal effects, and changes the permeability of microbial cell membranes, resulting in the destruction and death of a variety of microorganisms. Uses: Anti-infective agents, local. Group: Pharmaceutical. CAS No. 38146-42-8. Pack Sizes: 1 g. Product ID: B2699-064110. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Decane Impurities | Decane Impurities, prevalent in the analysis of hydrocarbon samples, are utilized in biomedical research to enhance the understanding of biological interactions at a molecular level. Although not directly used to treat specific diseases, they assist in drug formulation and quality control, indirectly supporting therapeutic developments for numerous conditions. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Decanol Impurities | Decanol Impurities, serving pivotal roles, underpin the biomedical landscape through facilitating pharmaceutical formulation analysis and refinement. By assuring decanol's purity, these impurities are instrumental in devising neurological, antimicrobial, and cardiovascular drugs, ensuring their optimization in safety and efficacy, thus anchoring advancements in pharmaceutical research and development. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Decapeptide-12 | Decapeptide-12 reversibly binds to tyrosinase, an enzyme found in a number of different pigment-producing cells. It prevents tyrosinase from catalyzing the oxidation of phenols, the first step in melanin production. Group: Pharmaceutical. CAS No. 137665-91-9. Pack Sizes: 5 mg. Product ID: BAT-006156. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Decarine | Decarine isolated from the roots of Zanthoxylum nitidum. It has low cytotoxicity towards human macrophages. Uses: Antibacterial activity. Group: Pharmaceutical. CAS No. 54354-62-0. Pack Sizes: 1 mg. Product ID: NP0243. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Decene Impurities | Decene Impurities play a crucial role in pharmaceutical synthesis processes, contributing to the production of intermediates essential for creating antiviral and anticancer drugs. These impurities are studied to ensure drug safety and efficacy, highlighting their importance in quality control within the biomedical industry. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Decinnamoyltaxagifine | Decinnamoyltaxagifine is extracted from the barks of Taxus chinensis var. mairei. Group: Pharmaceutical. CAS No. 130394-69-3. Pack Sizes: 1 mg. Product ID: NP1475. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Decitabine | Decitabine is a potent inhibitor of DNA methylation, used to treat myelodysplastic syndrome (MDS). Group: Pharmaceutical. CAS No. 2353-33-5. Pack Sizes: 4 g. Product ID: B2692-004252. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Decitabine Impurities | Decitabine Impurities, essential to the rigorous quality control of the chemotherapeutic agent decitabine, play a crucial role in oncological applications. Their meticulous analysis ensures purity and potency, protecting patient safety while optimizing therapeutic efficacy in combatting myelodysplastic syndromes and acute myeloid leukemia, thereby fortifying the treatment landscape. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Decursin | Decursin is a coumarin from The roots of Peucedanum ostruthium. Coumarins, such as decursinol and decursin, are known to be the major compounds of A. gigas. Angelica gigas roots have been widely used traditionally in Korean herbal medicine not only for the treatment of anaemia, but also as a sedative, an anodyne and a tonic. Studies have shown that decursin inhibits VEGF-mediated inner BRB breakdown through suppression of VEGFR-2 signaling pathway. And decursin is able to attenuate kainic acid-induced seizures and could have potential as an antiepileptic drug. Uses: Enzyme activators. Group: Pharmaceutical. CAS No. 5928-25-6. Pack Sizes: 5 mg. Product ID: B2703-479866. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Decursinol | Decursinol is a coumarin isolated from Angelica gigas. It shows anti-tumor and anti-metastasis activity. Group: Pharmaceutical. CAS No. 23458-02-8. Pack Sizes: 10 mg. Product ID: B2703-290082. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Decyl b-D-maltopyranoside | Decyl b-D-maltopyranoside is a nonionic surfactant that is commonly used to solubilize and stabilize membrane proteins. Group: Pharmaceutical. CAS No. 82494-09-5. Pack Sizes: 50 g. Product ID: B2705-354721. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Decylphosphonic acid | DPA doped polyaniline(PANI) can be used as a protective coating against corrosion. Decylphosphonic acid is an important raw material and intermediate used in organic synthesis, pharmaceuticals, agrochemicals and dyestuff. Uses: Dpa doped polyaniline(pani) can be used as a protective coating against corrosion. Group: Pharmaceutical. CAS No. 6874-60-8. Pack Sizes: 50 g. Product ID: B1370-190715. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Defactinib | Defactinib, also known as VS-6063 and PF-04554878, is an orally bioavailable, small-molecule focal adhesion kinase (FAK) inhibitor with potential antiangiogenic and antineoplastic activities. FAK inhibitor PF-04554878 inhibits FAK, which may prevent the integrin-mediated activation of several downstream signal transduction pathways, including ERK, JNK/MAPK and PI3K/Akt, thus inhibiting tumor cell migration, proliferation and survival. The tyrosine kinase FAK is , a signal transducer for integrins that is upregulated in many tumor cell types and is involved in tumor cell invasion, migration and proliferation. Group: Pharmaceutical. CAS No. 1073154-85-4. Pack Sizes: 200 mg. Product ID: B0084-462762. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Deferasirox | Deferasirox is an oral iron chelator used to treat chronic iron overload in patients receiving long term blood transfusions. Group: Pharmaceutical. CAS No. 201530-41-8. Pack Sizes: 250 mg. Product ID: NP3629. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Deferasirox Impurities | Deferasirox Impurities, intrinsic to the synthetic pathway of Deferasirox, constitute essential subjects in pharmaceutical examination, especially pertinent for individuals enduring chronic iron overload like beta-thalassemia patients. Meticulous assessment of these by-products is crucial in ensuring the therapeutic fidelity and efficacy of Deferasirox in alleviating acute iron toxicity. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Deflazacort Impurities | Deflazacort Impurities, indispensable for ensuring the purity of deflazacort, undergo rigorous analysis, crucial for therapeutic applications in Duchenne muscular dystrophy and inflammation. This meticulous scrutiny fortifies drug safety and efficacy, supporting formulation processes and quality assurance, thereby enhancing pharmaceutical innovations in the biomedical sector. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Defluoro Aprepitant | A metabolite of Aprepitant, a medication used to prevent chemotherapy-induced nausea and vomiting (CINV) and to prevent postoperative nausea and vomiting. Group: Pharmaceutical. CAS No. 170729-76-7. Pack Sizes: 100 mg. Product ID: B2694-466701. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Defluoro Levofloxacin | An impurity of Levofloxacin, which is as efficacious as or more efficacious than that with ciprofloxacin in systemic as well as pyelonephritis infections in mice. Group: Pharmaceutical. CAS No. 117620-85-6. Pack Sizes: 5 mg. Product ID: B0185-260156. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Defluoro Linezolid | Defluoro Linezolid is an impurity of Linezolid, which is an antibiotic used for the treatment of infections caused by Gram-positive bacteria. Group: Pharmaceutical. CAS No. 556801-15-1. Pack Sizes: 100 mg. Product ID: B2694-472430. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Degarelix | Degarelix acetate is a reversible gonadotropin-releasing hormone receptor (GnRHR) antagonist. Degarelix reduces the secretion of luteinizing hormone (LH) and testosterone via blocking GnRHR. Degarelix can be used for the treatment of prostate cancer. Group: Pharmaceutical. CAS No. 214766-78-6. Pack Sizes: 10 mg. Product ID: BAT-010776. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Degarelix acetate | Degarelix is a synthetic gonadotropin-releasing hormone receptor (GNRHR) antagonist. It decreases tumor volume of Dunning R3327H prostate tumor flank implants in rats when administered at a dose of 1 mg/kg per month. Formulations containing degarelix have been used in the treatment of advanced prostate cancer. Group: Pharmaceutical. CAS No. 934016-19-0. Pack Sizes: 250 mg. Product ID: BAT-016344. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Degarelix acetate hydrate | Degarelix acetate is a synthetic peptide that acts as a gonadotrophin-releasing hormone (GnRH) antagonist. Degarelix targets GnRH receptors in the pituitary gland, resulting in reduction of luteinizing hormone (LH), follicle-stimulating hormone (FSH) and suppression of testosterone. Group: Pharmaceutical. CAS No. 934246-14-7. Pack Sizes: 100 mg. Product ID: BAT-010777. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Degludec Impurities | Degludec Impurities are crucial in the biomedical industry for ensuring the purity and efficacy of insulin degludec formulations. By identifying and quantifying these impurities, researchers can refine pharmaceutical processes, ultimately aiding in the treatment of diabetes mellitus while maintaining drug safety and therapeutic effectiveness. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Dehydroabietic acid | Dehydroabietic acid is a diterpenoid found in Pinus sp. Group: Pharmaceutical. CAS No. 1740-19-8. Pack Sizes: 100 mg. Product ID: NP1759. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Dehydroacerogenin C | Dehydroacerogenin C is a natural compound with anti-cancer prowess aiding in the research of breast and lung malignancies. Group: Pharmaceutical. CAS No. 152041-27-5. Pack Sizes: 1 mg. Product ID: NP5072. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Dehydroandrographolide succinate | Dehydroandrographolide succinate (DAS), extracted from herbal medicine Andrographis paniculata (Burm f) Nees, has antibacterial and antiviral properties. Group: Pharmaceutical. CAS No. 786593-06-4. Pack Sizes: 25 mg. Product ID: B2703-033142. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Dehydro Aripiprazole-[piperazine-d8] Hydrochloride | Dehydro Aripiprazole-[piperazine-d8] Hydrochloride, is the labelled analogue of Dehydro Aripiprazole, which is a metabolite of Aripiprazole. Aripiprazole is an atypical antipsychotic indicated for schizophrenia and bipolar disorder. Group: Pharmaceutical. CAS No. 1215383-78-0. Pack Sizes: 10 mg. Product ID: BLP-002467. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Dehydrobruceantin | Dehydrobruceantin is extracted from the seeds of Brucea javanica (L.) Merr. It shows anti-tuberculosis activity. Group: Pharmaceutical. CAS No. 53662-98-9. Pack Sizes: 1 mg. Product ID: NP1389. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Dehydrobruceantinol | Dehydrobruceantinol is extracted from the seeds of Brucea javanica (L.) Merr. It tastes bitter and shows antileukemic activity. Group: Pharmaceutical. CAS No. 99132-99-7. Pack Sizes: 1 mg. Product ID: NP1362. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Dehydrocostus lactone | Dehydrocostus lactone and CL from root of S. lappa have anti-colorectal cancer activities through inhibiting Wnt/β-catenin pathway. Uses: Anti-colorectal cancer. Group: Pharmaceutical. CAS No. 477-43-0. Pack Sizes: 200 mg. Product ID: NP5782. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
Would you like to list your products on UK Chemical Suppliers?
Our database is helping our users find suppliers everyday.